DNA Synthesis Technologies and Services Market, 2022-2035 (Five Formats)

(1)

The DNA synthesis services market is anticipated to grow at an annualized rate of more than 15% by 2035, claims Roots Analysis

With growing applications of DNA in medical research, industry stakeholders are actively looking for technologies that not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability, and speed

Roots Analysis has announced the addition of “DNA Synthesis Technologies and Services Market, 2022-2035” report to its list of offerings.

With an increased focus on automating DNA synthesis technologies, several developers have incorporated robust automatic techniques that enable the engineering of biological systems and study genome in a high throughput manner

To order this 290+ page report, which features 130+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/dna-synthesis-market.html

Key Market Insights

Currently, more than 65 technology / service providers claim to offer DNA synthesis technologies and services

Majority of the stakeholders (53%) in this market claim to offer DNA synthesis services. A large proportion (56%) of these companies are small players, followed by mid-sized (28%) and large firms (18%).

Partnership activity within this domain has increased between 2017-2022

During the given time period, acquisition (40%) was the most common type of partnership model adopted by the companies involved in the DNA synthesis technologies and services domain. This was followed by technology licensing deals (20%), manufacturing (9%), product development (9%) and platform development agreements (6%).

Over USD 800 million has been invested by both private and public investors, since 2017 Of the total, close to USD 580 billion was raised through venture capital financing, representing around 40% of the overall investment. On the other hand, instances (29%) of grants were also reported, wherein players collectively raised more than USD 40 million.

(2)

Close to 1,300 articles related to DNA synthesis technologies and services, have been published in reputed scientific journals, since 2017

It is worth highlighting that more than 1,000 publications were related to research related information specific to DNA synthesis services; majority (36%) of these articles were published in North America.

1,000+ patents related to DNA synthesis technologies have been granted / filed by stakeholders, across the globe

Over the years, the annual number of patent applications filed in this domain has increased from 41 patent applications in 2017 to 70 patents in 2021. Interestingly, 70% of the patents in the domain were filed by industry players.

North America is anticipated to capture larger share of the DNA synthesis market by 2035

In terms of the method of DNA synthesis, the major share is captured by chemical method of DNA synthesis and the trend is unlikely to change in the foreseen future. Further, among the application areas, research and diagnostic applications are likely to hold the greater market share.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/dna-synthesis-market.html

Key Questions Answered

 Who are the leading industry players offering DNA synthesis technologies and services?

 What are the recent developments and emerging trends in the DNA synthesis technologies and services domain?

 Which partnership models are commonly adopted by industry stakeholders in the DNA synthesis technologies and services industry?

 Which are the leading funding organizations providing grants in the DNA synthesis industry?

 What is the trend of capital investments in the DNA synthesis technologies and services market?

 What is the focus of various publications related to DNA synthesis technologies and services?

(3)

 How has the intellectual property landscape for DNA synthesis technologies and services market evolved over the years?

 Which factors are likely to influence the evolution of the upcoming DNA synthesis technologies and services market?

 How is the current and future opportunity likely to be distributed across key market segments?

The financial opportunity within the DNA synthesis services market has been analyzed across the following segments:

 Type of DNA Synthesis Method

 Chemical Method

 Enzymatic Method

 Key Application Areas

 Research and Diagnostics

 Therapeutic Applications

 Key Geographical Regions

 North America

 Europe

 Asia Pacific and Rest of the World

The report features inputs from eminent industry stakeholder(s), who were very optimistic concerning the adoption of DNA synthesis technologies and services.

The report includes profiles of key players (listed below) engaged in the DNA synthesis technologies and services domain; each profile features a tabulated overview of company, product / service portfolio, recent developments, and an informed future outlook.

 Ajinomoto Bio-Pharma Services

 ATUM

 DNA Script

 Eurofins Genomics

 Gene Universal

(4)

 GenScript

 Synbio Technologies

You may also be interested in the following titles:

1. targeted protein degradation market , 2022-2035 2. Synthetic Biology: DNA Cloning Market, 2022-2035 3. Cell Invasion and Migration Assay Market , 2022-2035

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact:

Ben Johnson +1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

(5)

DNA synthesis has demonstrated to play a vital role in molecular and synthetic biology;

various DNA synthesis technologies facilitate the use of DNA across several applications, including drug discovery, genetic engineering and clinical diagnosis / treatment

Roots Analysis has announced the addition of “DNA Synthesis Technologies and Services Market, 2022-2035” report to its list of offerings.

The report features report features a detailed study of the current scenario and future potential of the DNA synthesis technologies and service providers. Further, the study underlines an in- depth analysis, highlighting the capabilities of service providers engaged in this domain. In addition to other elements, the study includes:

 A detailed assessment of the overall landscape of the DNA synthesis technologies and services market

 Elaborate profiles of the key players involved in providing technologies and services in the DNA synthesis domain

 A detailed overview of the current market landscape of oligonucleotide manufacturers focused on research and diagnostic applications, based on several relevant parame

 A detailed overview of the current market landscape of oligonucleotide manufacturers focused on therapeutic applications, based on several relevant parameters

 An analysis of the partnerships established between various stakeholders in this domain, during the period 2017-2022

 A review of the funding and investments made in the domain, in the period between 2017 and 2022

 An in-depth analysis of grants that have been awarded to various research institutes for projects related to DNA synthesis technologies and services

 A detailed review of more than 12,000 peer-reviewed, scientific articles related to research on DNA synthesis technologies

 An in-depth analysis of the patents related to DNA synthesis technologies, filed / granted till 2022

 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Method of DNA Synthesis

 Chemical Method

 Key Application Area(s)

(6)

 Therapeutics

 Company Size

 Small

 Mid-sized

 Large

 Key Geographical Region

 North America

 Europe

 Asia-Pacific and the Rest of the World

Key companies covered in the report:

 ATUM

 DNA Script

 Gene Universal

 GenScript

For additional details, please visit https://www.rootsanalysis.com/reports/dna-synthesis- market.html or email sales@rootsanalysis.com

4. targeted protein degradation market , 2022-2035 5. Synthetic Biology: DNA Cloning Market, 2022-2035 6. Cell Invasion and Migration Assay Market , 2022-2035

(7)

Contact:

Ben Johnson +1 (415) 800 3415

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

(8)

Roots Analysis has done a detailed study on “DNA Synthesis Technologies and Services Market, 2022-2035” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Key Market Insights

 Around 65 companies presently claim to have the required expertise for DNA synthesis technologies and affiliated services; of these, more than 50% players are small companies and have recently been established

 These technology and service providers claim to employ different cost-effective methods for the synthesis of DNA, having applications in various biomedical fields

 There has been a notable increase in the published scientific literature related to DNA synthesis technologies and services in the last few years; such articles have been published in over 50 countries

 The growing interest in DNA synthesis technologies and services is reflected by the increase in partnership activity in the recent past; in fact, between 2019 and 2021, the partnership activity increased at a CAGR of 18%

 Over the past few years, 150 academic grants have been awarded to various organizations in order to support the ongoing efforts related to research and innovation in the field of DNA synthesis technologies

 Several investors, having realized the future opportunity associated with DNA synthesis technologies and services market, have invested more than USD 750 million in the past five years

 More than 11,000 patents have been filed / granted related to DNA synthesis technologies since 2016, establishing a strong portfolio of intellectual property within this industry

 In the long term, the opportunity is likely to be segmented across methods of DNA synthesis, key application areas, company size and geography

(9)

Table of Contents

1. PREFACE

1.1. Scope of the Report 1.2. Research Methodology 1.3. Key Questions Answered 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Introduction to DNA Synthesis 3.3. Components of DNA Synthesis 3.3.1. Substrates

3.3.2. Template

3.3.3. Primer

3.3.4. Enzymes

3.3.5. Leading Strand Synthesis 3.3.6. Lagging Strand Synthesis 3.4. DNA Synthesis Technologies

3.4.1. Chemical Method of DNA Synthesis 3.4.2. Enzymatic Method of DNA Synthesis 3.5. Applications of DNA Synthesis 3.6. Future Perspectives

4. MARKET OVERVIEW: DNA SYNTHESIS TECHNOLOGIES AND SERVICES

4.2. DNA Synthesis Technologies and Services: Overall Market Landscape 4.2.1. Analysis by Type of Offering

(10)

4.2.2. Analysis by Method of DNA Synthesis 4.2.3. Analysis by Type of DNA Molecule 4.2.4. Analysis by Custom Offerings 4.2.5. Analysis by Application Area

4.3. DNA Synthesis Technologies and Services: Key Industry Players 4.3.1 Analysis by Year of Establishment

4.3.2 Analysis by Company Size

4.3.3. Analysis by Location of Headquarters 4.3.4. Analysis by Application Area and Region

5. COMPANY PROFILES

5.2. Ajinomoto Bio-Pharma Services 5.2.1. Company Overview

5.2.2. Financial Information

5.2.3. Technology / Service Portfolio

5.2.4. Recent Developments and Future Outlook

5.3. ATUM

5.3.1. Company overview

5.4. DNA Script

5.4.1. Company Overview

5.5. Eurofins Genomics 5.5.1. Company Overview 5.5.2. Financial Information

(11)

5.6. Gene Universal 5.6.1. Company Overview

5.7. GenScript

5.7.1. Company Overview 5.7.2. Financial Information

5.8. Synbio Technologies 5.8.1. Company overview

1. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (RESEARCH AND

DIAGNOSTIC APPLICATIONS) 6.1. Chapter Overview

6.2. Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications:

Overall Market Landscape

6.2.1. Analysis by Year of Establishment 6.2.2. Analysis by Company Size

6.2.3. Analysis by Scale of Operation 6.2.4. Analysis by Geographical Location

6.2.5. Analysis by Location of Manufacturing Facilities

6.2.6. Analysis by Regulatory Accreditations / Certifications Received 6.2.7. Analysis by Type of Oligonucleotide Manufactured

6.2.8. Analysis by Type of Offering

6.2.9. Analysis by Type of Manufacturing Service Offered 6.2.10. Analysis by Type of Modification

(12)

7. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (THERAPEUTIC APPLICATIONS)

7.2. Oligonucleotide Manufacturers Focused on Therapeutic Applications: Overall Market

Landscape

7.2.1. Analysis by Year of Establishment 7.2.2. Analysis by Company Size

7.2.3. Analysis by Scale of Operation 7.2.4. Analysis by Geographical Location

7.2.5. Analysis by Location of Manufacturing Facilities 7.2.6. Analysis by Regulatory Accreditations / Certifications 7.2.7. Analysis by Type of Oligonucleotide Manufactured 7.2.8. Analysis by Type of Offering

7.2.9. Analysis by Type of Manufacturing Service Offered 7.2.10. Analysis by Type of Modification

8. PARTNERSHIPS AND COLLABORATIONS

8.1. Chapter Overview 8.2. Partnership Models

8.3. DNA Synthesis Technologies and Services: List of Partnerships and Collaborations

8.3.1. Analysis by Year of Partnership 8.3.2. Analysis by Type of Partnership 8.3.3. Analysis by Type of Partner

8.3.4. Analysis by Year and Type of Partner

8.3.5. Most Active Players: Analysis by Number of Partnerships 8.3.6. Regional Analysis

8.3.6.1. Intercontinental and Intracontinental Agreements

9. FUNDING AND INVESTMENT ANALYSIS

9.1. Chapter Overview 9.2. Types of Funding

9.3. DNA Synthesis Technologies: Recent Funding Instances

(13)

9.4. Analysis by Year of Investment 9.5. Analysis by Amount Invested 9.5. Analysis by Amount Invested

9.6. Analysis by Type of Funding and Amount Invested 9.7. Analysis by Venture Capital Funding

9.8. Most Active Players: Analysis by Number of Funding Instances 9.9. Key Investors: Analysis by Number of Funding Instances 9.10. Regional Analysis by Amount Invested

9.11. Funding and Investment Summary

10. GRANT ANALYSIS

10.1 Chapter Overview

10.2. Analysis Methodology and Key Parameters

10.3. DNA Synthesis Technologies and Services: List of Academic Grants 10.3.1. Analysis by Year of Grant Award

10.3.2. Analysis by Grant Amount Awarded 10.3.3. Analysis by Administering Institute Center 10.3.4. Analysis by Support Period

10.3.5. Analysis by Administering Institute Center and Support Period 10.3.6. Analysis by Type of Grant Application

10.3.7. Analysis by Grant Activity Code 10.3.8. Word Cloud of Study Titles

10.3.9. Analysis by Purpose of Grant Award

10.3.10. Popular NIH Departments: Analysis by Number of Grants 10.3.11. Analysis by Type of Recipient Organization

10..12. Prominent Program Officers: Analysis by Number of Grants

11. PUBLICATION ANALYSIS

11.2. Analysis Methodology and Key Parameters 11.3. Analysis by Year of Publication

11.4. Analysis by Quarterly Distribution of Publication 11.5. Analysis by Type of Article

11.6. Analysis by Popular Keywords

(14)

11.7. Most Popular Authors: Analysis by Number of Publications 11.8. Popular Publishers: Analysis by Number of Publications 11.9. Popular Journals: Analysis by Number of Publications 11.10. Analysis by Therapeutic Area

11.11. Geographical Analysis

12. PATENT ANALYSIS

12.2. Analysis Methodology and Key Parameters

12.3. DNA Synthesis Technologies and Services: Patent Analysis 12.3.1. Analysis by Type of Patent

12.3.2. Analysis by Publication Year

12.3.3. Analysis by Type of Patent and Publication Year 12.3.3. Analysis by Issuing Authority

12.3.4. Analysis by CPC Symbols 12.3.5. Analysis by Type of Applicant

12.3.6. Word Cloud Analysis: Emerging Focus Areas

12.3.7. Leading Industry Players: Analysis by Number of Patents 12.3.8. Leading Non-Industry Players: Analysis by Number of Patents 12.3.9. Leading Players: Analysis by Number of Patents

12.3.10. Leading Patents: International Patents 12.3.11. Analysis by Patent Characteristics 12.3.12. Patent Valuation Analysis

13. DNA SYNTHESIS SERVICES: MARKET FORECAST AND OPPORTUNITY

ANALYSIS 13.1 Chapter Overview

13.2. Key Assumptions and Forecast Methodology

13.3. Global DNA Synthesis Services Market, 2022-2035

13.3.1. Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis,

2022-2035

13.3.2. Global DNA Synthesis Services Market: Distribution by Application Area, 2022-

(15)

2035

13.3.3. Global DNA Synthesis Services Market: Distribution by Company Size, 2022- 2035

13.3.4. Global DNA Synthesis Services Market: Distribution by Geography, 2022-2035

14. CONCLUDING REMARKS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

2. The Vaccine Adjuvants Market , 2022-2035

3. Synthetic Biology: DNA Cloning Market, 2022-2035

4. Cell Invasion and Migration Assay Market , 2022-2035

Contact:

Ben Johnson +1 (415) 800 3415

(16)

Around 65 companies presently claim to have the required expertise for DNA synthesis technologies and affiliated services; of these, more than 50% players are small companies and have recently been established, claims Roots Analysis

With an increased focus on automating DNA synthesis technologies, several developers have incorporated robust automatic techniques that enable the engineering of biological systems and study genome in a high throughput manner. This further leads to an increase in the yield of high-fidelity DNA fragments for use across several drug discovery and drug development processes

The financial opportunity within the DNA synthesis services market has been analyzed across the following segments:

 Chemical Method

 Therapeutics

 Company Size

 Small

 Mid-sized

 Large

 North America

 Europe

Key companies covered in the report:

 ATUM

 DNA Script

(17)

 Gene Universal

 GenScript

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview: DNA Synthesis Technologies and Services 5. Company Profiles

6. Case Study: Oligonucleotide Manufactureres (Research and Diagnostic Applications)

7. Case Study: Oligonucleotide Manufactureres (Therapeutic Applications) 8. Partnerships and Collaborations

9. Funding and Investment Analysis 10. Grant Analysis

11. Publication Analysis 12. Patent Analysis

13. DNA Synthesis Services: Market Forecast and Opportunity Analysis

14. Concluding Remarks

(18)

15. Appendix I: Tabulated Data

16. Appendix II: List of Companies and Organizations

Contact:

Ben Johnson +1 (415) 800 3415

(19)

The “DNA Synthesis Technologies and Services Market, 2022-2035” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these technologies and services over the next decade.

Key Inclusions

 A detailed assessment of the overall landscape of the DNA synthesis technologies and services market, providing information on type of offering, method of DNA synthesis (chemical method and enzymatic method), type of DNA molecule, custom offerings, and application area. Additionally, the report provides information on drug developer(s) involved in the domain, along with analyses based on a number of relevant parameters, such as year of establishment, company size and geographical location of headquarters.

 Elaborate profiles of the key players involved in providing technologies and services in the DNA synthesis domain. Each profile features a brief overview of the company, its financial information, details on its technology / service portfolio, financial information, and recent developments and an informed future outlook.

 A detailed overview of the current market landscape of oligonucleotide manufacturers focused on research and diagnostic applications, based on several relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical, and commercial), location of headquarters, number of manufacturing facilities, along with information on the location of facility (country-wise), regulatory accreditations and certifications received, type of oligonucleotide manufactured (antisense oligonucleotides, aptamers, decoys, miRNA, shRNA, siRNA, specialty amidites and others), type of offering (custom synthesis, modification and purification), type of manufacturing service(s) offered (process development and characterization, method validation and testing, analytical development, sequencing capabilities, stability studies, quality assurance and control, fill / finish, regulatory support, data analytics and reporting, and others) and type of modification(s) offered (amino modifiers, backbone modifications, fluorescent probes, dyes and quenchers, modified bases, phosphorylation, thiol modifications and others).

 A detailed overview of the current market landscape of oligonucleotide manufacturers focused on therapeutic applications, based on several relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical, and commercial),

(20)

location of headquarters, number of manufacturing facilities, along with information on the location of facility (country-wise), regulatory accreditations and certifications received, type of oligonucleotide manufactured (antisense oligonucleotides, aptamers, decoys, miRNA, shRNA, siRNA, specialty amidites and others), type of offering (custom synthesis, modification and purification), type of manufacturing service(s) offered (process development and characterization, method validation and testing, analytical development, sequencing capabilities, stability studies, quality assurance and control, fill / finish, regulatory support, data analytics and reporting, and others) and type of modification(s) (amino modifiers, backbone modifications, fluorescent probes, dyes and quenchers, modified bases, phosphorylation, thiol modifications and others).

 An analysis of the partnerships established between various stakeholders in this domain, during the period 2017-2022, covering product development and commercialization agreements, R&D agreements, technology licensing agreements, other licensing agreements, mergers and acquisitions, and other relevant types of deals.

 A review of the funding and investments made in the domain, in the period between 2017 and 2022, including seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings, at various stages of development. The analysis has been done on the basis of several parameters, such as number of funding instances, amount invested, type of funding, leading players and investors, and geographical analysis.

 An in-depth analysis of grants that have been awarded to various research institutes for projects related to DNA synthesis technologies and services, in the period between 2017 and 2022, on the basis of important parameters, such as year of grant award, grant amount awarded, administering institute center, support period, type of grant application, grant activity code, emerging focus area, purpose of grant award, type of recent organization, popular NIH department and prominent program officers.

 A detailed review of more than 12,000 peer-reviewed, scientific articles related to research on DNA synthesis technologies, which have been published between 2017 and 2022, including analysis based on parameters, such as year of publication, key focus area, type of article, popular keywords, popular authors, therapeutic area, geography and key journals (in terms of number of articles published in this domain and impact factor of the journal).

 An in-depth analysis of the patents related to DNA synthesis technologies, filed / granted till 2022, based on various parameters, such as patent publication year, geographical location / patent jurisdiction, CPC symbols, emerging focus areas, and type of applicant,

(21)

and leading players (by number of patents). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 Chemical Method

 Therapeutics

 Company Size

 Small

 Mid-sized

 Large

 North America

 Europe

To request sample pages, please visit this link

Key Questions Answered

 Who are the leading industry players offering DNA synthesis technologies and services?

 What are the recent developments and emerging trends in the DNA synthesis technologies and services domain?

 Which partnership models are commonly adopted by industry stakeholders in the DNA synthesis technologies and services industry?

 Which are the leading funding organizations providing grants in the DNA synthesis industry?

 What is the trend of capital investments in the DNA synthesis technologies and services market?

 What is the focus of various publications related to DNA synthesis technologies and services?

(22)

 How has the intellectual property landscape for DNA synthesis technologies and services market evolved over the years?

 Which factors are likely to influence the evolution of the upcoming DNA synthesis technologies and services market?

 How is the current and future opportunity likely to be distributed across key market segments?

5. The Vaccine Adjuvants Market , 2022-2035

6. Synthetic Biology: DNA Cloning Market, 2022-2035

7. Cell Invasion and Migration Assay Market , 2022-2035

Contact:

Ben Johnson +1 (415) 800 3415